Cargando…
Effectiveness of monoclonal antibody therapy for COVID-19 patients using a risk scoring system
INTRODUCTION: Monoclonal antibody therapy has been reported to be highly effective for preventing hospitalisation and severe cases in patients with Coronavirus Disease 2019 (COVID-19). However, since the drug is not readily available, it is important to rapidly and appropriately identify high-risk p...
Autores principales: | Mutoh, Yoshikazu, Umemura, Takumi, Ota, Aiko, Okuda, Keisuke, Moriya, Ryoma, Tago, Mayumi, Soejima, Kazuaki, Noguchi, Yoichiro, Bando, Tomohiro, Ota, Sho, Sato, Tomonori, Hirota, Shuko, Hagimoto, Satoshi, Takei, Reoto, Sasano, Hajime, Yamano, Yasuhiko, Kataoka, Kensuke, Yokoyama, Toshiki, Matsuda, Toshiaki, Kimura, Tomoki, Ichihara, Toshihiko, Kondoh, Yasuhiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8629723/ https://www.ncbi.nlm.nih.gov/pubmed/34863647 http://dx.doi.org/10.1016/j.jiac.2021.11.022 |
Ejemplares similares
-
Real-World Experience of the Comparative Effectiveness and Safety of Molnupiravir and Nirmatrelvir/Ritonavir in High-Risk Patients with COVID-19 in a Community Setting
por: Mutoh, Yoshikazu, et al.
Publicado: (2023) -
Acute exacerbation of idiopathic pulmonary fibrosis after SARS-CoV-2 vaccination
por: Bando, Tomohiro, et al.
Publicado: (2022) -
Two cases of acute respiratory failure following SARS‐CoV‐2 vaccination in post‐COVID‐19 pneumonia
por: Bando, Tomohiro, et al.
Publicado: (2022) -
Changes in patient-reported outcomes in patients with non-idiopathic pulmonary fibrosis fibrotic interstitial lung disease and progressive pulmonary fibrosis
por: Takei, Reoto, et al.
Publicado: (2023) -
Anti‐MDA5 antibody‐positive clinically amyopathic dermatomyositis with diffuse alveolar damage diagnosed by transbronchial lung cryobiopsy: A case report
por: Ishihara, Hiroyuki, et al.
Publicado: (2021)